Combined probiotic and melatonin supplementation in treatment of atopic dermatitis
Phase 3
Recruiting
- Conditions
- Atopic Dermatitis.Atopic dermatitis, unspecifiedL20.9
- Registration Number
- IRCT20170513033941N64
- Lead Sponsor
- Kashan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Children diagnosed with atopic dermatitis
Children aged 6-12 years
Exclusion Criteria
Patients who were receiving any systemic corticosteroid or other immunosuppressive drugs or taking antihistamines within the last 3 months before the study.
Children diagnosed with acquired immunosuppressive disease
Taking any antioxidant and/or anti-inflammatory supplements within 3 months prior to the enrollment.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SCORAD index. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: physical exmamination by pediatrician.
- Secondary Outcome Measures
Name Time Method